0.86p+0.06 (+7.50%)11 Apr 2025, 16:22
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Iq-Ai Limited Fundamentals

Company NameIq-Ai LimitedLast Updated2025-04-11
IndustryHealth Information ServicesSectorHealthcare
Shares in Issue246.710 mMarket Cap£2.12 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£-0.00EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio2.4810Cash Equity Ratio0.4296
Quick Ratio0.6790Current Ratio0.68
Price To Book Value4.8972ROCE0

Iq-Ai Limited Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Iq-Ai Limited Company Financials

Assets20232022
Tangible Assets£1,677.00£4,233.00
Intangible Assets£412,290.00£689,892.00
Investments00
Total Fixed Assets£413,967.00£694,125.00
Stocks00
Debtors£140,098.00£160,967.00
Cash & Equivalents£138,751.00£313,985.00
Other Assets00
Total Assets£720,736.00£1.21 m
Liabilities20232022
Creditors within 1 year£625,812.00£498,310.00
Creditors after 1 year00
Other Liabilities00
Total Liabilities£625,812.00£498,310.00
Net assets£94,924.00£707,073.00
Equity20232022
Called up share capital£1.91 m£1.83 m
Share Premium£20.58 m£20.58 m
Profit / Loss-£623,816.00-£511,601.00
Other Equity£94,924.00£707,073.00
Preference & Minorities00
Total Capital Employed£94,924.00£707,073.00
Ratios20232022
Debt Ratio00
Debt-to-Equity00
Assets / Equity2.48102.4810
Cash / Equity0.42960.4296
EPS£-0.00£-0.00
Cash Flow20232022
Cash from operating activities-£96,829.00-£374,671.00
Cashflow before financing-£96,829.00-£374,671.00
Increase in Cash-£175,234.00-£414,601.00
Income20232022
Turnover£609,390.00£535,886.00
Cost of sales£11,636.00£1,782.00
Gross Profit£597,754.00£534,104.00
Operating Profit-£406,324.00-£500,891.00
Pre-Tax profit-£623,816.00-£511,601.00

Iq-Ai Limited Company Background

SectorHealthcare
ActivitiesIQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies.Its geographical segment includes Jersey and the United States of America and reportable segments are holding company expenses and medical software. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.
Latest Interim Date13 Aug 2024
Latest Fiscal Year End Date29 Apr 2025

Iq-Ai Limited Directors

AppointedNamePosition
2016-05-06Mr. Stephen Sands CookExecutive Director,Chief Executive Officer and Company Secretary
2013-04-26Mr. John Henwood MBENon-Executive Director
2013-01-23Mr. Timothy Hugh Southcombe Trotter Non-Executive Director,Chairman
2013-04-30Mr. Paul R DavidsonNon-Executive Director,Chairman
2012-05-01Mr. Anthony GeeExecutive Director,Group Finance Director and Company sec
2013-04-26Mr. Gerald VoisinNon-Executive Director
2006-11-29Mr. Paul Ian FraserNon-Executive Director,Chairman
2011-08-09Mr. Mark Tristam Norwood DugdaleExecutive Director,Chief Executive
2011-08-09Mr. Graham Norton FCAExecutive Director,Finance Director and Company Secretary
2024-10-14Mr. Trevor Edward BrownExecutive Director,Chief Executive Officer
2024-11-19Mr. Vinod KaushalNon-Executive Director
2018-05-07Dr. Qu LiNon-Executive Director,Chairman
2024-03-05Mr. Michael SchmaindaNon-Executive Director
2024-03-05Mr. Brett SkellyNon-Executive Director

Iq-Ai Limited Contact Details

Company NameIQ-AI Ltd
AddressForum 4, Grenville Street, P. O. Box 264, St Helier, JE4 8TQ
Telephone
Websitehttps://www.imagingbiometrics.com

Iq-Ai Limited Advisors

SolicitorMJ Hudson
Phone+44 1534712900
RegistrarShare Registrars Limited
Phone+44 1252821390
Fax+44 1252719232
SolicitorCharles Russell Speechlys LLP
Phone+44 2072035000
StockbrokerPeterhouse Corporate Finance Ltd
Phone+44 2074690930
Fax+44 2072209798
Financial AdviserPeterhouse Corporate Finance Ltd
Phone+44 2074690930
Fax+44 2072209798
AuditorWelbeck Associates
Phone+44 2074671700
BankBarclays Bank PLC
Financial PR AdviserSmithfield Consultants
Phone+44 2030472000
AuditorDeloitte LLP